The global single-cell omics market, valued at USD 1.61 billion in 2023, is projected to escalate to USD 5.36 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 16.2% from 2024 to 2031. This growth underscores the transformative impact of single-cell analysis technologies in advancing biomedical research, precision medicine, and understanding cellular...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian